This NDC is on FDA's drug shortage list (posted Nov 3, 2023)

Product Information

CROMOLYN 100 MG/5 ML ORAL CONC is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3357 per ML under NDC 16571060096. Its NADAC has been published 629 times since Nov 28, 2013.

FDA first approved this application on Oct 27, 2011. Its Orange Book therapeutic-equivalence code is AA.

CROMOLYN 100 MG/5 ML ORAL CONC

CROMOLYN SODIUM
$0.3357per ML

Strength

100 mg/5mL

NDC

16571060096

Classification

Generic

Dosage Form

SOLUTION, CONCENTRATE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CROMOLYN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA202583

FDA Approved

10/27/2011

TE Code

AA

On Market Since

12/5/2011

Pharmacological Classes

Decreased Histamine Release
Mast Cell Stabilizer

Price Statistics

The NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has been published 629 times since Nov 28, 2013, and over the history we have for it it has declined 62.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3357 per ML
All-time high$1.0317 (Jun 10, 2015)
All-time low$0.1665 (Nov 20, 2024)
52-week high$0.3364
52-week low$0.3141
Median price$0.4788
Average price$0.5785
Largest weekly change+85.7% (Jan 17, 2024)
Weeks tracked629
Tracking sinceNov 28, 2013

Price History

1W

+6.9%

1M

+6.9%

3M

-0.1%

6M

+24.6%

1Y

+24.6%

3Y

+2.5%

5Y

-21.2%

All

-62.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CROMOLYN 100 MG/5 ML ORAL CONC?

The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 100 MG/5 ML ORAL CONC, manufactured by Rising Pharma Holdings Inc., is $0.3357 per ML (NDC 16571060096), effective Aug 19, 2026.

How has the price of CROMOLYN 100 MG/5 ML ORAL CONC changed over time?

Over the history we have for it, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has declined 62.3%. It has been tracked across 629 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CROMOLYN 100 MG/5 ML ORAL CONC?

Since Nov 28, 2013, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has ranged from a low of $0.1665 (Nov 20, 2024) to a high of $1.0317 (Jun 10, 2015), with a median of $0.4788 per ML.

Are there cheaper alternatives to CROMOLYN 100 MG/5 ML ORAL CONC?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CROMOLYN 100 MG/5 ML ORAL CONC in a comparable dosage form, but none are currently priced below it.

Who manufactures CROMOLYN 100 MG/5 ML ORAL CONC?

CROMOLYN 100 MG/5 ML ORAL CONC (NDC 16571060096) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.

Is CROMOLYN 100 MG/5 ML ORAL CONC in shortage?

Yes — NDC 16571060096 is currently listed in FDA's drug shortage database (posted Nov 3, 2023).